Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Background  Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to describe the severity and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:TH Open
Autors principals: Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.
Format: Artigo
Idioma:Inglês
Publicat: Georg Thieme Verlag KG 2019
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524922/
https://ncbi.nlm.nih.gov/pubmed/31249989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1685496
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars